Activation of the TLR2/MyD88/NF-κB pathway elevates the autocrine secretion of VEGF and MMP9 in MDA-MB-231 cells, recognized as pivotal factors for breast cancer cell invasion and adhesion (27). Here, MYD88 is linked to breast carcinoma.